Hereditary angioedema with a focus on the child

Allergy and Asthma Proceedings

Volumn 36, Issue 1, 2015, Pages 70-73

  Bennett, Gregory ^a   Craig, Timothy ^b  

^a PENN STATE CHILDREN S HOSPITAL   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B2 RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C1S INHIBITOR;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARM EDEMA; ARTICLE; CHILD; CHILDHOOD MORTALITY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ELECTRONIC MEDICAL RECORD; FACE EDEMA; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HUMAN; LABORATORY DIAGNOSIS; LEG EDEMA; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PATIENT INFORMATION; PUBLICATION; RESPIRATORY TRACT DISEASE; SCROTAL SWELLING; ANGIOEDEMAS, HEREDITARY; COMORBIDITY; INFANT; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; ANGIOEDEMAS, HEREDITARY; CHILD; CHILD, PRESCHOOL; COMORBIDITY; COMPLEMENT C1 INACTIVATOR PROTEINS; FEMALE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES;

EID: 84919725848     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2015.36.3806     Document Type: Article

References (29)

1. Zuraw BL. HAE therapies: past present and future. Allergy Asthma Clin Immunol 6:23, 2010.
2. Bork K, Meng G, Staubach P, and Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 119:267-274, 2006.
3. Davis AE 3rd. The pathophysiology of hereditary angioedema. Clin Immunol 114:3-9, 2005.
4. Farkas H, Varga L, Széplaki G, et al. Management of hereditary angioedema in pediatric patients. Pediatrics 120:e713-e722, 2007.
5. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6:24, 2010.
6. Craig T, Aygören-Pürsün E, Bork K, et al. WAO guideline for the management of hereditary angioedema. World Allergy Organ J 5:182-199, 2012.
7. MacGinnitie AJ. Pediatric hereditary angioedema. Pediatr Allergy Immunol 25:420-427, 2014.
8. Donaldson VH, and Rosen FS. Hereditary angioneurotic edema: a clinical survey. Pediatrics 37:1017-1027, 1966.
9. Nielsen EW, Johansen HT, Holt J, and Mollnes TE. C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pediatr Res 35:184-187, 1994.
10. Sardana N, and Craig TJ. Recent advances in management and treatment of hereditary angioedema. Pediatrics 128:1173-1180, 2011.
11. Craig TJ, Rojavin MA, Machnig T, et al. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks. Ann Allergy Asthma Immunol 111:211-215, 2013.
12. Aberer W. Hereditary angioedema treatment options: the availability of new therapies. Ann Med 44:523-529, 2012.
13. Schneider L, Hurewitz D, Wasserman R, et al. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies. Pediatr Allergy Immunol 24:54-60, 2013.
14. Carugati A, Pappalardo E, Zingale LC, and Cicardi M. C1-inhibitor deficiency and angioedema. Mol Immunol 38:161-173, 2001.
15. MacGinnitie AJ, Davis-Lorton M, Stolz LE, and Tachdjian R. Use of ecallantide in pediatric hereditary angioedema. Pediatrics 132:e490-e497, 2013.
16. Wahn V, Aberer W, Eberl W, et al. Hereditary angioedema (HAE) in children and adolescents - a consensus on therapeutic strategies. Eur J Pediatr 171:1339-1348, 2012.
17. Kreuz W, Rusicke E, Martinez-Saguer I, et al. Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema. Transfusion 52:100-107, 2012.
18. Krishnamurthy A, Naguwa SM, and Gershwin ME. Pediatric angioedema. Clin Rev Allergy Immunol 34:250-259, 2008.
19. Kjaer L, and Bygum A. Hereditary angioedema in childhood: a challenging diagnosis you cannot afford to miss. Pediatr Dermatol 30:94-96, 2013.
20. Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 26:653-668, 2006.
21. Nielsen EW, and Gramstad S. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand 50:120-122, 2006.
22. Caballero T, Aygören-Pürsün E, Bygum A, et al. The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe. Allergy Asthma Proc 35:47-53, 2014.
23. Wilson DA, Bork K, Shea EP, et al. Economic costs associated with acute attacks and long-term management of hereditary angioedema. Ann Allergy Asthma Immunol 104:314-320, 2010.
24. Farkas H. Pediatric hereditary angioedema due to C1-inhibitor deficiency. Allergy Asthma Clin Immunol 6:18, 2010.
25. Bygum A, Fagerberg CR, Ponard D, et al. Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency. Allergy 66:76-84, 2011.
26. Bork K, Hardt J, and Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 130:692-697, 2012.
27. Abbassi V. Growth and normal puberty. Pediatrics 102(2 Pt 3):507-511, 1998.
28. Bewtra AK, Levy RJ, Jacobson KW, et al. C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life. Allergy Asthma Proc 33:427-431, 2012.
29. Bernstein JA. HAE update: epidemiology and burden of disease. Allergy Asthma Proc 34:3-6, 2013.